Evidence map›Paper›PMID 37101253›Full record

ArticleCellular & molecular biology letters2023

Protection of melatonin treatment and combination with traditional antibiotics against septic myocardial injury.

Wencheng Di, Zhenxiao Jin, Wangrui Lei, Qiong Liu, Wenwen Yang, Shaofei Zhang, Chenxi Lu, Xiaoling Xu, Yang Yang, Huadong Zhao

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  10. IPCellular & molecular biology letters · 2024
    Article
  11. Article
  12. Targeting AMP-activated protein kinase in sepsis.Frontiers in endocrinology · 2024
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Wencheng Di *Department of Cardiovascular Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, 29 Bulan Road, Shenzhen, Guangdong Province, China.
Zhenxiao Jin *Department of Cardiovascular Surgery, Xijing Hospital, The Airforce Military Medical University, 127 Changle West Road, Xi'an, China.
Wangrui Lei *Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Qiong LiuKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Wenwen YangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Shaofei ZhangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Chenxi LuKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Xiaoling XuKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China.
Yang YangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, 229 Taibai North Road, Xi'an, China. yang200214yy@nwu.edu.cn.ORCID http://orcid.org/0000-0002-1163-2359
Huadong ZhaoDepartment of General Surgery, Tangdu Hospital, The Airforce Military Medical University, 1 Xinsi Road, Xi'an, China. huadongzhaotd@163.com.
Ministry of Education of the People's Republic of China · CNShenzhen Third People’s Hospital · CNTang Du Hospital · CNXijing Hospital · CN

Funding

Innovation Capability Strong Foundation Plan of Xi'an City 21YXYJ0037National Natural Science Foundation of China 81871607National Natural Science Foundation of China 82070422Youth Science and Technology Rising Star Project of Shaanxi Province 2020KJXX-036
6 · The paper itself

Abstract

backgroundHeart failure is a common complication of sepsis with a high mortality rate. It has been reported that melatonin can attenuate septic injury due to various properties. On the basis of previous reports, this study will further explore the effects and mechanisms of melatonin pretreatment, posttreatment, and combination with antibiotics in the treatment of sepsis and septic myocardial injury. METHODS AND

resultsOur results showed that melatonin pretreatment showed an obvious protective effect on sepsis and septic myocardial injury, which was related to the attenuation of inflammation and oxidative stress, the improvement of mitochondrial function, the regulation of endoplasmic reticulum stress (ERS), and the activation of the AMPK signaling pathway. In particular, AMPK serves as a key effector for melatonin-initiated myocardial benefits. In addition, melatonin posttreatment also had a certain degree of protection, while its effect was not as remarkable as that of pretreatment. The combination of melatonin and classical antibiotics had a slight but limited effect. RNA-seq detection clarified the cardioprotective mechanism of melatonin.

conclusionAltogether, this study provides a theoretical basis for the application strategy and combination of melatonin in septic myocardial injury.

Indexed as

MelatoninSepsisAMP-Activated Protein KinasesAnti-Bacterial AgentsHumansMyocardiumAMP-Activated Protein KinasesAnti-Bacterial AgentsMelatoninAntibioticsMelatoninPosttreatmentPretreatmentRNA-seqSeptic myocardial injury

Identifiers

PMID37101253
PMCPMC10134561
OpenAlexW4367050616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.